Table 2.
Participant demographics for short and long illness duration.
| Short | Long | |
|---|---|---|
| Mean Age (years ± stdev)** | 24.3 ± 3.9 | 43.1 ± 11.0 |
| Gender (M/F) | 13/6 | 10/11 |
| Mean Education Level (years ± stdev) | 13.1 ± 1.0 | 12.8 ± 2.0 |
| Smoking Status (Yes/No) | 4/19 | 7/21 |
| Mean Illness Duration (years ± stdev) | 2.7 ± 1.7 | 21.2 ± 10.3 |
| Cognitive Variables | ||
| Matrics Composite Score (mean ± stdev) | 32.7 ± 13.4 | 24.6 ± 13.7 |
| UPSA Score (mean ± stdev) | 94.6 ± 13.2 | 80.7 ± 22.3 |
| LOF Score (mean ± stdev) | 24.7.2 ± 4.4 | 21.9 ± 5.7 |
| Symptom Ratings | ||
| BPRS total score (mean ± stdev) | 37.2 ± 6.8 | 39.0 ± 9.2 |
| BPRS positive score (mean ± stdev) | 7.1 ± 3.3 | 8.6 ± 3.7 |
| BPRS negative score (mean ± stdev) | 6.7 ± 2.3 | 6.9 ± 2.3 |
| BNSS score (mean ± stdev) | 14.1 ± 9.2 | 18.2 ± 11.3 |
| Chlorpromazine Equivalents (mean ± stdev) | 290.9 ± 286.0 | 372.8 ± 362.8 |
statistically significant (p < 0.05).